Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moleculin Biotech CS (NQ: MBRX )

0.6545 +0.0245 (+3.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,362
Open 0.6107
Bid (Size) 0.6050 (27)
Ask (Size) 0.7091 (3)
Prev. Close 0.6300
Today's Range 0.6102 - 0.6546
52wk Range 0.5604 - 1.940
Shares Outstanding 29,675,510
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
MBRX Stock Earnings: Moleculin Biotech Misses EPS Estimates
MBRX stock earnings for Q1 show Moleculin Biotech reporting a wider per-share loss than analysts expected. 
Via InvestorPlace

Performance

YTD
-38.83%
-38.83%
1 Month
-17.86%
-17.86%
3 Month
-45.46%
-45.46%
6 Month
-49.26%
-49.26%
1 Year
-55.78%
-55.78%

More News

Read More
Moleculin Biotech: Q1 Earnings Insights
Via Benzinga
Moleculin Biotech's Earnings: A Preview
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
What's Going On With Moleculin Biotech Stock Today?
Via Benzinga
Earnings Outlook For Moleculin Biotech
Via Benzinga
Moleculin Biotech's Potential Antiviral Compound Selected For NIAID-Funded Animal Studies
Via Benzinga
Moleculin Reveals Final Topline Data From European Study Of Annamycin In Leukemia Setting
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Moleculin Biotech's Annamycin In Leukemia Study Shows 80% Overall Response Rate
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Celularity, Moleculin Biotech And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Moleculin Biotech Doses Healthy Volunteers For Covid-19 In Early-Stage Study Of WP1122
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.